share_log

谱尼测试(300887.SZ):目前未开展生物合成业务

Penile test (300887.SZ): Currently no biosynthesis business

Gelonghui Finance ·  May 8 06:20

Gelonghui, May 8 | Puni Test (300887.SZ) said on the investor interactive platform that Hubei Zhongjia Synthetic Pharmaceutical Co., Ltd. has a GMP production system and production capacity for APIs, and is the “last mile” to open up a one-stop biomedical technology platform for the company. At this point, the Penney Group can provide full-process technical support for biomedical research and development. Currently, there is no biosynthesis business.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment